Cargando…

Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets

BACKGROUND: Passively acquired maternal derived immunity (MDI) is a double-edged sword. Maternal derived antibody-mediated immunity (AMI) and cell-mediated immunity (CMI) are critical immediate defenses for the neonate; however, MDI may interfere with the induction of active immunity in the neonate,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandrick, Meggan, Theis, Kara, Molitor, Thomas W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065585/ https://www.ncbi.nlm.nih.gov/pubmed/24903770 http://dx.doi.org/10.1186/1746-6148-10-124

Ejemplares similares

Transfer of Mycoplasma hyopneumoniae-specific cell mediated immunity to neonatal piglets
por: Biebaut, Evelien, et al.
Publicado: (2021)

One Dose of a Novel Vaccine Containing Two Genotypes of Porcine Circovirus (PCV2a and PCV2b) and Mycoplasma hyopneumoniae Conferred a Duration of Immunity of 23 Weeks
por: Mancera Gracia, José Carlos, et al.
Publicado: (2021)

Development of a Multi-Epitope Vaccine for Mycoplasma hyopneumoniae and Evaluation of Its Immune Responses in Mice and Piglets
por: Li, Gaojian, et al.
Publicado: (2022)

Safety of the Administration of an Inactivated PCV2a/PCV2b/Mycoplasma Hyopneumoniae Vaccine to Pregnant and Lactating Sows and Gilts
por: Pérez, Elena, et al.
Publicado: (2023)

Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection
por: Sibila, Marina, et al.
Publicado: (2009)

The immune mechanism of Mycoplasma hyopneumoniae 168 vaccine strain through dendritic cells
por: Shen, Yumeng, et al.
Publicado: (2017)

Long-term follow-up of Mycoplasma hyopneumoniae-specific immunity in vaccinated pigs
por: Biebaut, Evelien, et al.
Publicado: (2023)

Comparison of immune responses to intranasal and intrapulmonary vaccinations with the attenuated Mycoplasma hyopneumoniae 168 strain in pigs
por: LI, Pengcheng, et al.
Publicado: (2015)

Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs
por: Maes, Dominiek, et al.
Publicado: (2021)

Innate and adaptive immune responses of snatch-farrowed porcine-colostrum-deprived pigs to Mycoplasma hyopneumoniae vaccination
por: Huang, Yanyun, et al.
Publicado: (2014)

Pathogenicity & virulence of Mycoplasma hyopneumoniae
por: Leal Zimmer, Fernanda M. A., et al.
Publicado: (2020)

Toll-Like Receptor 2 (TLR2) and TLR4 Mediate the IgA Immune Response Induced by Mycoplasma hyopneumoniae
por: Li, Xia, et al.
Publicado: (2019)

Intrinsic terminators in Mycoplasma hyopneumoniae transcription
por: Fritsch, Tiago Ebert, et al.
Publicado: (2015)

Selective medium for culture of Mycoplasma hyopneumoniae
por: Cook, Beth S., et al.
Publicado: (2016)

Control of Mycoplasma hyopneumoniae infections in pigs
por: Maes, D., et al.
Publicado: (2008)

Genomic Variability and Post-translational Protein Processing Enhance the Immune Evasion of Mycoplasma hyopneumoniae and Its Interaction With the Porcine Immune System
por: Li, Gaojian, et al.
Publicado: (2020)

Different local, innate and adaptive immune responses are induced by two commercial Mycoplasma hyopneumoniae bacterins and an adjuvant alone
por: Beuckelaere, Lisa, et al.
Publicado: (2022)

Porcine antibody profiles of 33 Mycoplasma hyopneumoniae fusion proteins from M. hyopneumoniae natural infection but not vaccination
por: Ning, Yaru, et al.
Publicado: (2022)

Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter
por: Mechler-Dreibi, Marina L., et al.
Publicado: (2021)

Transcription Analysis of the Porcine Alveolar Macrophage Response to Mycoplasma hyopneumoniae
por: Bin, Li, et al.
Publicado: (2014)

Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins
por: Matthijs, Anneleen M. F., et al.
Publicado: (2019)

Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age
por: Pleguezuelos, Patricia, et al.
Publicado: (2022)

Repetitive Elements in Mycoplasma hyopneumoniae Transcriptional Regulation
por: Cattani, Amanda Malvessi, et al.
Publicado: (2016)

Extracellular Actin Is a Receptor for Mycoplasma hyopneumoniae
por: Raymond, Benjamin B. A., et al.
Publicado: (2018)

Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions
por: Garcia-Morante, Beatriz, et al.
Publicado: (2017)

Field evaluation of piglet vaccination with a Mycoplasma hyopneumoniae bacterin as compared to a ready-to-use product including porcine circovirus 2 and M. hyopneumoniae in a conventional French farrow-to-finish farm
por: Duivon, Didier, et al.
Publicado: (2018)

NADH oxidase of Mycoplasma hyopneumoniae functions as a potential mediator of virulence
por: Hao, Fei, et al.
Publicado: (2022)

A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs
por: Kristensen, Charlotte S, et al.
Publicado: (2014)

Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae
por: Matthijs, Anneleen Marguerite Filip, et al.
Publicado: (2019)

Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
por: Pendarvis, Ken, et al.
Publicado: (2014)

MLVA typing of Mycoplasma hyopneumoniae bacterins and field strains
por: Tamiozzo, P., et al.
Publicado: (2015)

Survey on Mycoplasma hyopneumoniae gilt acclimation practices in Europe
por: Garza-Moreno, Laura, et al.
Publicado: (2017)

Influence of pig gut microbiota on Mycoplasma hyopneumoniae susceptibility
por: Surendran Nair, Meera, et al.
Publicado: (2019)

Construction of Mycoplasma hyopneumoniae P97 Null Mutants
por: Clampitt, Jeannett M., et al.
Publicado: (2021)

Genotyping and biofilm formation of Mycoplasma hyopneumoniae and their association with virulence
por: Wu, Yuzi, et al.
Publicado: (2022)

Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and Mycoplasma hyopneumoniae against a dual PCV2d and Mycoplasma hyopneumoniae challenge
por: Ham, Sehyeong, et al.
Publicado: (2023)

Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2
por: Tao, Yu, et al.
Publicado: (2020)

Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae
por: Wang, Yongheng, et al.
Publicado: (2019)

Optimization of culture media of pathogenic Mycoplasma hyopneumoniae by a response surface methodology
por: Hwang, Mi-Hyun, et al.
Publicado: (2010)

Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs
por: Arsenakis, Ioannis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cbh7j5ectl2tib4lu0k2pl7ig8